Evidence map›Paper›PMID 32316225›Full record

ArticleDiagnostics (Basel, Switzerland)2020

Increased

Araceli García-Martínez, Beatriz López-Muñoz, Carmen Fajardo, Rosa Cámara, Cristina Lamas, Sandra Silva-Ortega, Ignacio Aranda, Antonio Picó

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Araceli García-MartínezResearch Laboratory, Hospital General Universitario de Alicante-Institute for Health and Biomedical Research (ISABIAL), 03010 Alicante, Spain.ORCID 0000-0002-1052-1315
Beatriz López-MuñozDepartment of Endocrinology & Nutrition, Hospital General Universitario de Alicante-ISABIAL, 03010 Alicante, Spain.
Carmen FajardoDepartment of Endocrinology and Nutrition, Hospital La Ribera, Alzira, 46600 Valencia, Spain.
Rosa CámaraDepartment of Endocrinology & Nutrition, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.
Cristina LamasDepartment of Endocrinology & Nutrition, Hospital General Universitario de Albacete, 02006 Albacete, Spain.ORCID 0000-0003-4622-9508
Sandra Silva-OrtegaDepartment of Pathology, Hospital General Universitario de Alicante -ISABIAL, 03010 Alicante, Spain.
Ignacio ArandaDepartment of Pathology, Hospital General Universitario de Alicante -ISABIAL, 03010 Alicante, Spain.
Antonio PicóDepartment of Endocrinology & Nutrition, Hospital General Universitario de Alicante, Miguel Hernández University, 03010 Alicante, Spain.
Hospital General Universitario de Alicante Doctor Balmis · ESHospital de La Ribera · ESHospital General Universitario de Albacete · ESHospital Universitari i Politècnic La Fe · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

Pfizer WS1568384
6 · The paper itself

Abstract

miR-17-5p and

Indexed as

E2F1microRNAsmiR-17~92pituitary neuroendocrine tumours

Identifiers

PMID32316225
PMCPMC7235816
OpenAlexW3016330143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.